この専門家をプロジェクトに採用したいですか？ 見積もりを依頼 無料で。
プロフィール詳細
Dr. Leila R.に依頼
Iran
I am Leila Rahbarnia, an assistant professor in medical biotechnology at Tabriz University of Medical Sciences.
プロフィール概要
専門分野
サービス
Writing
Medical Writing
職務経験
Affiliated Assistant Professor
Tabriz University of Medical Sciences
8月 2018 - 現在
assistant professor
Research Center for Infectious Diseases and Tropical Medicine, Tabriz University of Medical Sciences
7月 2017 - 現在 
学歴
PhD
Tabriz University of Medical Sciences Drug Applied Research Center
7月 2012 - 現在
Phd biotechnology
Tabriz University of Medical Science
9月 2012 - 1月 2016
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
Leila Rahbarnia, Samaneh Jahandar-Lashaki, Safar Farajnia, Aref Faraji-Barhagh, Zahra Hosseini, Nasim Bakhtiyari (2025). Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update . Molecular Biotechnology.
Leila Rahbarnia, Parisa Mansouri Rad, Azam Safary, Azizeh ShadiDizaji, Zahra Maani (2024). The Synthetic Antimicrobial Peptide Derived From Melittin Displays Low Toxicity and Anti-infectious Properties . Probiotics and Antimicrobial Proteins.
Leila Rahbarnia, Milad Tolouie, Safar Farajnia, Davoud Farajzadeh, Ali Rabbizadeh Saray (2024). Critical Point Mutations in the RBD of SARS-COV-2 Involved in Binding to ACE2 . Molecular Genetics, Microbiology and Virology.
Leila Rahbarnia, Safar Farajnia, Nazli Khajehnasiri, Habib Zarredar (2023). Correction to: Design of a hybrid peptide derived from melittin and CXCL14 –C17: a molecular dynamics simulation study . Biologia.
Leila Rahbarnia, Zahra Maani, Safar Farajnia, Elaheh Zadeh Hosseingholi, Nazli Khajehnasiri, Parisa Mansouri (2023). Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interaction . Journal of Molecular Structure.
Maani, Z., Farajnia, S., Rahbarnia, L., Hosseingholi, E.Z., Khajehnasiri, N., Mansouri, P.(2023). Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interaction . Journal of Molecular Structure. 1272.
Shadman, Z., Ghasemali, S., Farajnia, S., Mortazavi, M., Biabangard, A., Khalili, S., Rahbarnia, L.(2023). In silico Validation of Pseudomonas aeruginosa Exotoxin A Domain I Interaction with the Novel Human scFv Antibody . Infectious Disorders - Drug Targets. 23. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 31-37.
Shanehbandi, D., Asadi, M., Seyedrezazadeh, E., Zafari, V., Shekari, N., Akbari, M., Rahbarnia, L., Zarredar, H.(2023). MicroRNA-Based Biomarkers in Lung Cancer: Recent Advances and Potential Applications . Current Molecular Medicine. 23. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 648-667.
Wunrow, H.Y., Bender, R.G., Vongpradith, A., Sirota, S.B., Swetschinski, L.R., Novotney, A., Gray, A.P., Ikuta, K.S., Sharara, F., Wool, E.E., et al.(2023). Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 . The Lancet Neurology. 22. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 685-711.
Nabizadeh, S., Rahbarnia, L., Nowrozi, J., Farajnia, S., Hosseini, F.(2023). Rational design of hybrid peptide with high antimicrobial property derived from Melittin and Lasioglossin . Journal of Biomolecular Structure and Dynamics.
Sheikhzadeh, B.H., Rahbarnia, L., Dehnad, A., Naghili, B., Saffarian, P.(2023). The high cross-transmission in methicillin resistant Staphylococcus aureus between healthy and patient communities . Iranian Journal of Microbiology. 15. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 408-413.
Farajnia, S., Rahbarnia, L., Khajehnasiri, N., Zarredar, H.(2023). Correction to: Design of a hybrid peptide derived from melittin and CXCL14 –C17: a molecular dynamics simulation study (Biologia, (2022), 77, 8, (2269-2280), 10.1007/s11756-022-01067-x) . Biologia. 78. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 3001.
Rad, P.M., Rahbarnia, L., Safary, A., ShadiDizaji, A., Maani, Z.(2023). The Synthetic Antimicrobial Peptide Derived From Melittin Displays Low Toxicity and Anti-infectious Properties . Probiotics and Antimicrobial Proteins.
Leila Rahbarnia, Fariba Lotfi, Mostafa Akbarzadeh-Khiavi, Ziba Lotfi, Azam Safary, Habib Zarredar, Amir Baghbanzadeh, Behrooz Naghili, Behzad Baradaran (2022). Correction to: Micronutrient therapy and effective immune response: a promising approach for management of COVID-19 . Infection.
Leila Rahbarnia, Mostafa Akbarzadeh-Khiavi, Mitra Torabi, Amir-Hossein Olfati, Azam Safary (2022). Bio-nano scale modifications of melittin for improving therapeutic efficacy . Expert Opinion on Biological Therapy.
Leila Rahbarnia, Mostafa Akbarzadeh-Khiavi, Mitra Torabi, Azam Safary (2022). Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection . Infection.
Leila Rahbarnia, Safar Farajnia, Nazli Khajehnasiri, Habib Zarredar (2022). Design of a hybrid peptide derived from Melittin and CXCL14 –C17: A molecular dynamics simulation study . Biologia.
Akbarzadeh-Khiavi, M., Torabi, M., Rahbarnia, L., Safary, A.(2022). Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection . Infection. 50. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 295-308.
Farajnia, S., Rahbarnia, L., Khajehnasiri, N., Zarredar, H.(2022). Design of a hybrid peptide derived from Melittin and CXCL14 –C17: A molecular dynamics simulation study . Biologia. 77. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2269-2280.
Lotfi, F., Shojaie, M., Rahbarnia, L., Dehnad, A., Naghili, B., Lotfi, H.(2022). Molecular characterization and genetic diversity of multidrug- and extensively drug-resistant A. baumannii clinical isolates . Gene Reports. 26.
Ghasemali, S., Farajnia, S., Barzegar, A., Rahmati, M., Negahdari, B., Rahbarnia, L., Yousefi-Nodeh, H.(2022). Rational Design of Anti-Angiogenic Peptides to Inhibit VEGF/VEGFR2 Interactions for Cancer Therapeutics . Anti-Cancer Agents in Medicinal Chemistry. 22. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2026-2035.
Farajnia, S., Lotfi, F., Dehnad, A., Shojaie, M., Raisi, R., Rahbarnia, L., Bazmani, A., Naghili, B., Shiry, S.(2022). The molecular characterization of colistin-resistant isolates of Acinetobacter baumannii from patients at intensive care units . Iranian Journal of Microbiology. 14. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 319-327.
Ikuta, K.S., Swetschinski, L.R., Aguilar, G.R., Sharara, F., Mestrovic, T., Gray, A.P., Weaver, N.D., Wool, E.E., Han, C., Hayoon, A.G., et al.(2022). Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 . The Lancet. 400. (10369). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2221-2248.
Lotfi, F., Akbarzadeh-Khiavi, M., Lotfi, Z., Rahbarnia, L., Safary, A., Zarredar, H., Baghbanzadeh, A., Naghili, B., Baradaran, B.(2022). Correction to: Micronutrient therapy and effective immune response: a promising approach for management of COVID-19 (Infection, (2021), 49, 6, (1133-1147), 10.1007/s15010-021-01644-3) . Infection. 50. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1051.
Akbarzadeh-Khiavi, M., Torabi, M., Olfati, A.-H., Rahbarnia, L., Safary, A.(2022). Bio-nano scale modifications of melittin for improving therapeutic efficacy . Expert Opinion on Biological Therapy. 22. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 895-909.
Leila Rahbarnia, Fariba Lotfi, Mostafa Akbarzadeh-Khiavi, Ziba Lotfi, Azam Safary, Habib Zarredar, Amir Baghbanzadeh, Behrooz Naghili, Behzad Baradaran (2021). Micronutrient therapy and effective immune response: a promising approach for management of COVID-19 . Infection.
Leila Rahbarnia, Maryam Dashtiahangar, Safar Farajnia, Arash Salmaninejad, Arezoo Gowhari Shabgah, Samaneh Ghasemali(2021). Anti-cancer Immunotoxins, Challenges, and Approaches . Current Pharmaceutical Design. 27. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 932--941. Bentham Science Publishers Ltd.
Dashtiahangar, M., Rahbarnia, L., Farajnia, S., Salmaninejad, A., Shabgah, A.G., Ghasemali, S.(2021). Anti-cancer immunotoxins, challenges, and approaches . Current Pharmaceutical Design. 27. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 932-941.
Rahbarnia, L., Farajnia, S., Naghili, B., Saeedi, N.(2021). Comparative evaluation of nested polymerase chain reaction for rapid diagnosis of human brucellosis . Archives of Razi Institute. 76. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 203-211.
Bahadori, A., Gökmen, T.G., Köksal, F., Tumgor, G., Agin, M., Sadighi, A., Ziaee, M., Rahbarnia, L.(2021). High prevalence of clarithromycin resistant Helicobacter pylori in Turkish children with gastric disorders . Gene Reports. 24.
Shadman, Z., Farajnia, S., Pazhang, M., Tohidkia, M., Rahbarnia, L., Najavand, S., Toraby, S.(2021). Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa . BMC Infectious Diseases. 21. (1).
Aftabi, Y., Ansarin, K., Shanehbandi, D., Khalili, M., Seyedrezazadeh, E., Rahbarnia, L., Asadi, M., Amiri-Sadeghan, A., Zafari, V., Eyvazi, S., et al.(2021). Long non-coding RNAs as potential biomarkers in the prognosis and diagnosis of lung cancer: A review and target analysis . IUBMB Life. 73. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 307-327.
Saadati, M., Rahbarnia, L., Farajnia, S., Naghili, B., Mohammadzadeh, R.(2021). The prevalence of biofilm encoding genes in multidrug-resistant Acinetobacter baumannii isolates . Gene Reports. 23.
Lotfi, F., Akbarzadeh-Khiavi, M., Lotfi, Z., Rahbarnia, L., Safary, A., Zarredar, H., Baghbanzadeh, A., Naghili, B., Baradaran, B.(2021). Micronutrient therapy and effective immune response: a promising approach for management of COVID-19 . Infection. 49. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1133-1147.
Leila Rahbarnia, Alireza Dehnad, Mohammad Hossein Ghaffari Agdam, Behrooz Naghili, Parvaneh Saffarian(2020). Detection of hemolysine genes in methicillin-resistant S. aureus isolates obtained from a healthy population in north-west of Iran . Gene Reports. 21. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 100874. Elsevier {BV}
Leila Rahbarnia, Safar Farajnia, Hajar Khaneshi, Hadi Farajnia, Behrooz Naghili, Asghar Tanomand(2020). Detection of blaOXA-23 and blaNDM-1 carbapenemase among clinical isolates of A. baumannii in Tabriz, north-west of Iran . Gene Reports. 18. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 100555. Elsevier {BV}
Rahbarnia, L., Farajnia, S., Khaneshi, H., Farajnia, H., Naghili, B., Tanomand, A.(2020). Detection of blaOXA-23 and blaNDM-1 carbapenemase among clinical isolates of A. baumannii in Tabriz, north-west of Iran . Gene Reports. 18.
Nazari, A., Farajnia, S., Zahri, S., Bagherlou, N., Tanoumand, A., Rahbarnia, L.(2020). Cytoplasmic chaperones enhance soluble expression of anti-egfr huscfv in escherichia coli . Iranian Journal of Biotechnology. 18. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 67-74.
Ghasemali, S., Farajnia, S., Barzegar, A., Rahmati-Yamchi, M., Baghban, R., Rahbarnia, L., Nodeh, H.R.Y.(2020). New developments in anti-angiogenic therapy of cancer, review and update . Anti-Cancer Agents in Medicinal Chemistry. 21. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 3-19.
Dehnad, A., Agdam, M.H.G., Rahbarnia, L., Naghili, B., Saffarian, P.(2020). Detection of hemolysine genes in methicillin-resistant S. aureus isolates obtained from a healthy population in north-west of Iran . Gene Reports. 21.
Leila Rahbarnia, Fatemeh Ravanbakhsh Ghavghani, Behrooz Naghili, Alireza Dehnad, Ahad Bazmani, Mojtaba Varshochi, Mohammad Hossein Ghaffari Agdam(2019). Nasal and extra nasal MRSA colonization in hemodialysis patients of north-west of Iran . BMC Research Notes. 12. (1). Springer Science and Business Media {LLC}
Leila Rahbarnia, Vahideh Ahmadzadeh, Safar Farajnia, Roghayyeh Baghban, Habib Zarredar(2019). CRISPR‐Cas system: Toward a more efficient technology for genome editing and beyond . Journal of Cellular Biochemistry. 120. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 16379--16392. Wiley
Leila Rahbarnia, Safar Farajnia, Behrooz Naghili, Vahideh Ahmadzadeh, Kamal Veisi, Roghayyeh Baghban, Sayna Toraby(2019). Current trends in targeted therapy for drug-resistant infections . Applied Microbiology and Biotechnology. 103. (20). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 8301--8314. Springer Science and Business Media {LLC}
Rahbarnia, L., Farajnia, S., Naghili, B., Ahmadzadeh, V., Veisi, K., Baghban, R., Toraby, S.(2019). Current trends in targeted therapy for drug-resistant infections . Applied Microbiology and Biotechnology. 103. (20). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 8301-8314.
Ahrabi, S.Z., Rahbarnia, L., Dehnad, A., Naghili, B., Agdam, M.H.G., Nazari, A.(2019). Incidence of oxacillin-susceptible meca-positive staphylococcus aureus (OS-MRSA) isolates and TSST-1 virulence factor among high school students in tabriz, Northwest of Iran . Archives of Clinical Infectious Diseases. 14. (4).
Baghban, R., Farajnia, S., Rajabibazl, M., Ghasemi, Y., Mafi, A.A., Hoseinpoor, R., Rahbarnia, L., Aria, M.(2019). Yeast Expression Systems: Overview and Recent Advances . Molecular Biotechnology. 61. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 365-384.
Ahmadzadeh, V., Farajnia, S., Baghban, R., Rahbarnia, L., Zarredar, H.(2019). CRISPR-Cas system: Toward a more efficient technology for genome editing and beyond . Journal of Cellular Biochemistry. 120. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 16379-16392.
Ghavghani, F.R., Rahbarnia, L., Naghili, B., Dehnad, A., Bazmani, A., Varshochi, M., Ghaffari Agdam, M.H.(2019). Nasal and extra nasal MRSA colonization in hemodialysis patients of north-west of Iran . BMC Research Notes. 12. (1).
Dariushnejad, H., Farajnia, S., Zargami, N., Khosroshahi, S.A., Rahbarnia, L.(2018). Dsbc chaperone mediated soluble expression of human TNF-α in E. coli . Minerva Biotecnologica. 30. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 14-21.
Akbari, B., Farajnia, S., Zarghami, N., Mahdieh, N., Rahmati, M., Khosroshahi, S.A., Barzegar, A., Rahbarnia, L.(2017). Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A . Anti-Cancer Drugs. 28. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 263-270.
Rahbarnia, L., Farajnia, S., Babaei, H., Majidi, J., Veisi, K., Khosroshahi, S.A., Tanomand, A.(2017). Development of a novel human scFv against EGFR L2 domain by phage display technology . Current Pharmaceutical Design. 23. (13). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2009-2014.
Rahbarnia, L., Farajnia, S., Babaei, H., Majidi, J., Veisi, K., Ahmadzadeh, V., Akbari, B.(2017). Evolution of phage display technology: from discovery to application . Journal of Drug Targeting. 25. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 216-224.
Akbari, B., Farajnia, S., Ahdi Khosroshahi, S., Safari, F., Yousefi, M., Dariushnejad, H., Rahbarnia, L.(2017). Immunotoxins in cancer therapy: Review and update . International Reviews of Immunology. 36. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 207-219.
Leila Rahbarnia, Safar Farajnia, Hossein Babaei, Jafar Majidi, Kamal Veisi, Asghar Tanomand, Bahman Akbari(2016). Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technology . Biologicals. 44. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 567--573. Elsevier {BV}
Rahbarnia, L., Farajnia, S., Babaei, H., Majidi, J., Veisi, K., Tanomand, A., Akbari, B.(2016). Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technology . Biologicals. 44. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 567-573.
Akbari, B., Farajnia, S., Zarghami, N., Mahdieh, N., Rahmati, M., Khosroshahi, S.A., Rahbarnia, L.(2016). Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR) . Protein Expression and Purification. 127. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 8-15.
Ahdi Khosroshahi, S., Farajnia, S., Ghiamirad, M., Tanomand, A., Veisi, K., Rahbarnia, L., Akbari, B.(2016). Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR) . Protein Expression and Purification. 120. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 59-64.
Rahbarnia, L., Farajnia, S., Babaei, H., Majidi, J., Akbari, B., Khosroshahi, S.A.(2016). Development of a novel human single chain antibody against EGFRvIII antigen by phage display technology . Advanced Pharmaceutical Bulletin. 6. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 563-571.
Rahbarnia, L., Farajnia, S., Babaei, H., Majidi, J., Dariushnejad, H., Hosseini, M.K.(2016). Isolation and characterization of a novel human scFv inhibiting EGFR vIII expressing cancers . Immunology Letters. 180. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 31-38.
Jalalypour, F., Farajnia, S., Mahmoudi, F., Baradaran, B., Farajzadeh, D., Majidi, J., Rahbarnia, L.(2014). Cloning and expression of the variable regions of anti-EGFR monoclonal antibody in E. coli for production of a single chain antibody . Iranian Journal of Biotechnology. 12. (2).
Farajnia, S., Ahmadzadeh, V., Tanomand, A., Veisi, K., Khosroshahi, S.A., Rahbarnia, L.(2014). Development trends for generation of single-chain antibody fragments . Immunopharmacology and Immunotoxicology. 36. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 297-308.
Farajnia, S., Peerayeh, S.N., Tanomand, A., Majidi, J., Goudarzi, G., Naghili, B., Rahbarnia, L.(2014). Protective efficacy of recombinant exotoxin A — flagellin fusion protein against Pseudomonas aeruginosa infection . Canadian Journal of Microbiology. 61. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 60-64.
Rahbarnia, L., Farajnia, S., Naghili, B.(2012). Application of DsbA signal peptide for soluble expression of Leishmania infantum P4 Nuclease in E. coli . Asian Journal of Animal and Veterinary Advances. 7. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 326-333.
Pooshaneh, S., Farajnia, S., Soleimani Dorjag, M., Rahbarnia, L., Ansarin, Kh., Sohrabi, N., Peymani, A.(2012). Prevalence of extended-spectrum β-lactamase class A among Acinetobacter baumannii isolates from patients of Imam Reza hospital, Tabriz . Pharmaceutical Sciences. 17. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 225-232.
Farajnia, S., Rahbarnia, L., Maleki Zanjani, B., Alimohammadian, M.H., Abdoli Oskoee, S., Beh-Pajooh, A., Saeedi, N., Montazer Saheb, S.(2011). Molecular cloning and characterization of P4 nuclease from Leishmania infantum . Enzyme Research. 2011. (1).
Application of DsbA Signal Peptide for Soluble Expression of Leishmania infantum P4 Nuclease in E. coli. Asian Journal of Animal and Veterinary Advances.
Cloning and Expression of the Variable Regions of Anti-EGFR Monoclonal Antibody in E. coli for Production of a Single Chain Antibody. Iranian Journal of Biotechnology.
Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aerugi. Anti-cancer drugs.
Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR). Protein expression and purification.
Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR). Protein expression and purification.
Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology. Advanced pharmaceutical bulletin.
Development of a Novel Human scFv Against EGFR L2 Domain by Phage Display Technology. Current pharmaceutical design.
Development trends for generation of single-chain antibody fragments. Immunopharmacology and immunotoxicology.
Evolution of phage display technology: from discovery to application. Journal of drug targeting.
Immunotoxins in cancer therapy: Review and update. International Reviews of Immunology.
Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technology. Biologicals.
Isolation and characterization of a novel human scFv inhibiting EGFR vIII expressing cancers. Immunology letters.
Molecular cloning and characterization of P4 nuclease from Leishmania infantum. Enzyme research.
Protective efficacy of recombinant exotoxin A-flagellin fusion 1 protein against Pseudomonas aeruginosa infection. Canadian journal of microbiology.
Seroprevalence of Helicobacter pylori infection in patients suffering from gastric symptoms in the Northwest of Iran. African Journal of Microbiology Research.
Tongue carcinoma&58; case series and demographic analysis. Journal of Analytical Research in Clinical Medicine.
OTHER
Leila Rahbarnia, Alireza Dehnad, Rana Khosravi Rad, Behrooz Naghili, Aysan Golipor(2020). The Prevalence of ACME-arcA and PVL Genes Among Staphylococcus Aureus Isolates in a Student Population from North-West of Iran . Research Square
Dehnad, A., Rad, R.K., Rahbarnia, L., Naghili, B., Golipor, A.(2020). The Prevalence of ACME-arcA and PVL Genes Among Staphylococcus Aureus Isolates in a Student Population from North-West of Iran . Research Square.
leila rahbarnia, Safar Farajnia, Behrooz Naghili, Nazli Saeedi(2019). Comparative evaluation of nested PCR for diagnosis of human brucellosis . Research Square
Rahbarnia, L., Farajnia, S., Naghili, B., Saeedi, N.(2019). Comparative evaluation of nested PCR for diagnosis of human brucellosis . Research Square.
CONFERENCE POSTER
Isolation of human SCFV antibody against EGFR L2 domain by screening of human SCFV phage library. 1st Tabriz International Life Science Conference and 12th Iran Biophysical.
評価とコメント
受注プロジェクト総数:
コメント: